MedPath

SINGULAIR

These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR (montelukast sodium) tablets, chewable tablets, and oral granulesInitial U.S. Approval: 1998

Approved
Approval ID

78eea56d-15a6-4ceb-b755-d1a3e9707f32

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

montelukast sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-221
Application NumberNDA020829
Product Classification
M
Marketing Category
C73594
G
Generic Name
montelukast sodium
Product Specifications
Route of AdministrationORAL
Effective DateJuly 31, 2008
FDA Product Classification

INGREDIENTS (11)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
montelukast sodiumActive
Quantity: 10 mg in 1 1
Code: U1O3J18SFL
Classification: ACTIM
lactose monohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
hydroxypropyl celluloseInactive
Code: RFW2ET671P
Classification: IACT

montelukast sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-565
Application NumberNDA020830
Product Classification
M
Marketing Category
C73594
G
Generic Name
montelukast sodium
Product Specifications
Route of AdministrationORAL
Effective DateJuly 31, 2008
FDA Product Classification

INGREDIENTS (8)

mannitolInactive
Code: 3OWL53L36A
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
montelukast sodiumActive
Quantity: 5 mg in 1 1
Code: U1O3J18SFL
Classification: ACTIM
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
hydroxypropyl celluloseInactive
Code: RFW2ET671P
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
aspartameInactive
Code: Z0H242BBR1
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SINGULAIR - FDA Drug Approval Details